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Abstract 
Pluripotent stem cells (PSCs) have the potential to revolutionize biomedical science; however, while 
it is simple to reproducibly obtain comparable, stable cell lines in mouse, those produced from 
human material typically show significant variability both within and between cell lines. This is likely 
due to differences in the cell identity of conventional mouse and human PSCs. It is hoped that 
recently identified conditions to reprogram human cells to a naïve-like state will produce better PSCs 
resulting in reproducible experimental outcomes and more consistent differentiation protocols. In 
this review we discuss the latest literature on the discovery of human naïve-like stem cells and 
examine how similar they are to both mouse naïve cells and the preimplantation human epiblast. 
  
Introduction 
Studies in mouse embryonic stem cells (mESCs) over many years have led to a detailed 
understanding of this cell state. While mouse cells are typically grown in a state of naïve 
pluripotency, equivalent to the naïve epiblast of the preimplantation blastocyst [1], human cells are 
cultured in primed pluripotency conditions. These are more similar to the postimplantation epiblast 
where cells become primed for differentiation [2]. Consequently, there are significant difficulties in 
directly applying our knowledge from mouse ESCs to human systems.  
There have been several attempts to generate mouse-like human naïve pluripotent stem cells 
(nPSCs) over recent years. Most often when putative human naïve cells are generated in vitro they 
are analysed using criteria that are known to distinguish mouse naïve cells from primed cells. Such 
criteria include responses to extrinsic and intrinsic signalling pathways, the biophysical, biochemical 
and metabolic status of the cells, and the overall epigenetic and transcriptomic cell identity. 
However, recent advances in our understanding of the human embryo also allow direct comparisons 
to the naïve compartment in vivo. Recently, cells exhibiting human naïve epiblast molecular features 
have been described [3-5]. Over the course of this review we shall examine how closely these match 
the state of both mouse naïve ESCs and what is known of the human blastocyst. 
Transcriptional identity 
 The transcriptional identity of a cell is often considered to be a readout of the cell’s state (Figure 1, 
part 1). However, it is clear that the transcriptional state of cells is plastic, and a range of genes 
fluctuate in response to intra- and extracellular conditions. Historically, it has not been practical to 
get a large number of high quality human embryos, necessary to obtain replicates of transcriptomic 
data with sufficient depth. Also, such embryos may be compromised as they have to be cultured in 
vitro in order to generate blastocyst-like embryos. Importantly, recent advances in RNA sequencing, 
particularly protocols for small cell numbers and even single cell sequencing, have made the analysis 
of these embryos possible. 
Using such techniques, Yan et al. [6], and more recently Blakeley et al. [7], obtained single-cell 
transcript data from human embryos including late blastocyst stage embryos. Yan et al. observed 
four distinct cell types by unsupervised clustering which appear to represent two trophectoderm 
populations as well as extra-embryonic endoderm and epiblast cells based on their expression of 
known marker genes, as expected in a mature blastocyst. However, both studies identified only a 
handful of epiblast cells, giving a fairly small sample size for further analysis. 
Comparing the human naïve induced pluripotent stem cells (hniPSCs) of Takashima et al., the 
embryo derived human naïve ESCs (hnESCs) from Guo et al. [5], the embryonic naïve epiblast cells 
from Yan and from Blakeley, as well as mouse nESCs and conventional primed human ESCs, it is clear 
that the hniPSCs and embryo-derived hnESCs cluster closely together [5]. This indicates that they 
share a transcriptional identity. Notably, the human naïve-like cell lines cluster closer to mouse ESCs 
than to human blastocyst cells along a principle component of variation. It is possible that this 
separation is the result of generic adaptation of cells to in vitro culture. Interestingly, established 
human primed lines are separated from primed epiblast outgrowths along this same axis.  
Theunissen et al. took a different approach to comparing their datasets to published human embryo 
data. They identified genes that are expressed in specific embryonic stages in the dataset of Yan et 
al. They then looked for the proportion of these genes that were differentially expressed between 
their hniPSCs and conventional primed hESCs. While genes specifically expressed in embryonic 
epiblast were enriched in the hniPSCs, so were genes specific to the morula and all other cell types 
of the late blastocyst [8]. This is surprising, since unsupervised clustering of all single cells in the 
study by Yan et al. [6] indicated that these are well defined states, with epiblast cells segregating 
well from other cells of the blastocyst. As stated by Theunissen et al. [8], this may indicate that their 
hniPSCs are in an earlier embryonic state, perhaps before full segregation of the inner cell mass. By 
analysing the expression of transposable elements, they found striking similarities between their 
cells and morula blastomeres. Interestingly, recent work from Petropoulos et al. [9] suggests that the 
segregation of lineages occurs relatively late in human embryos, with co-expression of lineage-
specific genes throughout the morula. The three lineages only begin to segregate on the onset of 
blastocyst formation.  
Transcription factor network 
At the core of the naïve cell identity in mouse ESCs is a highly interconnected transcription factor 
network which shows remarkable redundancy [10,11] (Figure 1, part 2). Whereas the complete 
transcriptome may not be identical between cell lines and across passages, these factors are always 
expressed in naïve cells. They are also functionally conserved across a range of vertebrates in their 
ability to drive induction of naïve pluripotent stem cells [12–14]. Additionally, many of these factors 
are specific for nPSCs compared to primed post-implantation epiblast derived stem cells 
(EpiSCs) [2] making these a good subset of genes to use as markers of a naïve state. Takashima, Guo 
and Theunissen all investigated a panel of these genes and found that most were upregulated in 
their putative hniPSCs and hnESCs relative to primed cells [3-5]. Neither ESRRB nor KLF2 were 
upregulated in any of these naïve lines; however, this may be due to differences between primate 
and rodent and the redundant use of paralogue genes such as Klf4 [1,4,7]. It is interesting, however, 
that both Takashima and Theunissen were able to efficiently induce a naïve-like state through 
exogenous expression of KLF2 alongside NANOG. Takashima elegantly demonstrated that the 
behaviour of the transcription factor network in his hniPSCs closely corresponded to that of mouse 
ESCs with a knockout and rescue strategy. Mouse ESCs can support the single loss of either Esrrb or 
Tfcp2l1 due to redundancies in the network [15,16], but it is expected that double knockout would 
lead to network collapse and subsequent differentiation [4]. Accordingly, shRNA depletion of 
TFCP2L1 resulted in greatly reduced colony formation, indicating that most cells had stopped self-
renewing. Application of exogenous ESRRB during this knockdown was able to rescue self-renewal. 
Together this provides strong evidence that an interactive transcription network highly similar to 
that in mouse is active in these cells. 
Exogenous ligands and Intracellular signalling landscape 
A broad array of signalling pathways interact to maintain or destabilise the naïve state in mouse ESCs 
(Figure 1, part 3). These cells are able to self-renew in the absence of external signals providing that 
certain pro-differentiation pathways are blocked, namely the MEK/ERK MAPK signalling axis and the 
GSK3β pathway which normally destabilised the network in part through its role in the degradation 
of β-catenin [17]. However, these conditions are not optimal and extrinsic signals that enhance 
pluripotency and survivability are often added to the culture. Most common, is the LIFR/GP130 
ligand LIF which activates the JAK/STAT pathway [18,19]. This is typically included with inhibitors of 
GSK3β and MEK to give chemically defined 2i LIF medium. This enhances the efficiency of induced 
naïve pluripotency [17,20] and maintains mouse naïve PSCs in a state closely resembling the naïve 
epiblast of the pre-implantation embryo [1,17,20]. 
Given the importance of LIF and downstream JAK/STAT signalling in reprogramming and 
maintenance of mouse naïve PSCs [21,22] and its ability to induce human cells with some naïve-like 
properties [23,24], it was surprising that Theunissen et al. [3] found hLIF to be dispensable for 
culture of their hniPSCs. Indeed their microarray data (publically accessible on the GEO database, 
accession GSE59435) indicates that LIFR expression is four-fold lower in naïve cells than in their 
parental primed cells. In addition, Takashima et al. [4] show that LIFR is expressed at a far lower level 
in hniPSCs than in mouse ESCs. While LIF signalling is a key feature of the mouse blastocyst and is 
important for survival in diapause [25], it is also known to be important in the process of 
implantation in both mouse and humans [26,27]. Further work will be required to test whether 
JAK/STAT signalling is indeed an important component of the human naïve state.  
In mouse, Fgf2 and Activin A are both used to support the undifferentiated growth of primed EpiSCs 
[2,28,29], while Fgf signalling leads to differentiation of naïve ESCs and Activin signalling is 
dispensable [17,29–31]. While the current human naïve cells can be maintained in the absence of 
FGF and Activin [3,4], Theunissen et al. identified increased differentiation on their double inhibition 
[3]. Notably in mouse, following activation by LIF stimulation, JAKs activate PI3K and the AKT 
signalling pathway [32]. This appears to have a role in ESC self-renewal, with cells treated with a PI3K 
or PDK1 inhibitor showing reduced proliferation and increased multi-lineage differentiation [33,34]. 
The PI3K/AKT pathway is known to be activated downstream of both FGF and Activin A / TGFβ 
signalling in various contexts [29,35,36], but most interestingly FGF2-induced AKT activation has 
been demonstrated in conventional primed human ESCs, where it is proposed to boost cell survival 
[37]; in this manner, FGF/Activin could be beneficial to the human naïve-like state in the absence of 
sufficient LIF signalling to induce the AKT signalling cascade.  
Given the poor survival of hniPSCs Theunissen et al. [3] found it necessary to maintain these with 
ROCK inhibitor. While ROCK inhibitor was found not to be strictly required by Takashima et al. [4], it 
was used in combination with their t2iL+Gö in feeder-free culture and embryo derivation [4,5]. In 
mouse, poor survival on single-cell passaging is a more common trait in primed cells [2], which can 
be similarly rescued with application of ROCK inhibitor [38]. The precise manner in which ROCKi 
contributes to the enhancement of self-renewal is not clear. It appears that following single-cell 
dissociation, loss of focal adhesions between cells leads to activation of RHO/ROCK signalling. This 
results in enhanced actinomyosin contractility which induces apoptosis [39,40]. The improved 
proliferation observed while culturing the hniPSCs in the presence of ROCKi may suggest that they 
are not responding appropriately to cell-cell and cell-substrate contacts (Figure 1, part 4).  In mouse, 
a switch from E-Cadherin expression in naive ESCs to N-cadherin in primed EpiSCs has been observed 
[41,42]. Examination of the microarray data from Theunissen et al. reveals a decrease in N-Cadherin 
on transition to the naive state; however, both N- and E-cadherin are expressed in primed human 
ESCs, and there is no further increase in E-cadherin in the naive cells [8]. It could be interesting to 
examine other cell contact-sensing pathways such as YAP/TAZ signalling to see if they are 
compromised. Interestingly, it has been suggested that overexpression of YAP promotes the 
reprogramming of human primed cells to a naïve-like identity [43]. 
Epigenetic fingerprint 
Another distinctive feature of most cell states, and particularly the naïve state, is the epigenetic 
landscape (Figure 1, part 5). In mouse ESCs cultured in 2i LIF, there is a remarkable genome-wide 
reduction in DNA methylation which is also observed in vivo [44–46]. It has been unclear until 
recently whether this should also be expected in humans [47,48]. However, recent work suggests 
that DNA methylation shows the same trend in human as in mouse [49]. In line with this, 
Theunissen, Guo and Takashima all identified a decrease in global DNA methylation [4,5,8], on the 
order of that observed in human embryos [49]. Beyond this global decrease, however, there are 
signs that DNA methylation may not be properly regulated in these cells. Imprinted loci are 
specifically marked by methylation on one of the parental chromosomes. Stable imprints are 
retained throughout development and can still be found in differentiated cells. Importantly, they are 
observed in primed human ESCs. On conversion to naïve conditions, however, many of these marks 
are lost [50], which is an issue as this is linked to poor differentiation in vitro and shows links to 
developmental disorders and tumourogenisis [51].  
Another epigenetic property of mouse naïve ESCs is the absence of a silent X-chromosome in 
females resulting in the presence of two active X-chromosomes (Figure 1, part 6). On fertilization, 
the paternal X-chromosome is specifically inactivated [52] and is only reactivated in the naïve 
epiblast at the blastocyst stage [52–55]. Shortly after implantation of the embryo a random X-
chromosome is inactivated [56]. There has been some debate over the state in human blastocysts 
[57,58], but recent evidence shows that they do have two active X-chromosomes [9]. In the early 
human female blastocyst, cells exhibit twice the amount of X-linked gene expression compared to 
counterpart male embryo cells [9]. However, despite maintaining biallelic expression as the 
blastocyst develops further, transcription of X-linked genes is downregulated, a phenomenon 
termed “dampening” of the X-chromosome [9]. 
 
The status of the X-chromosome in primed cells has also been somewhat contentious [59–61]. 
Primed cells have undergone X-inactivation, and there is no reactivation when reprogramming 
human somatic cells to primed iPSCs [61]. However, over prolonged culture of primed pluripotent 
cells, a phenomenon of erosion of X-inactivation can be observed [60–62]. It appears that expression 
of Xist, the master regulator of X-inactivation, becomes epigenetically silenced resulting in the 
subsequent activation of genes on the formerly inactive chromosome. This makes the presence of 
two active X chromosomes in primed human ESCs an epigenetic abnormality rather than a molecular 
feature of biological significance. 
 
Recently, it was shown that in the reprogramming of human primed cells to a naïve-like state the 
silent X-chromosome reactivates [8,63]. Despite exhibiting biallelic expression, it was found that X-
linked gene expression was not twice that of the cells of origin which contained a silent X 
chromosome [63]. Instead it resembled the “dampening” phenomenon observed in vivo in very late 
human blastocysts [8,9,63]. Upon differentiation there was inactivation of the X chromosome. 
However, this was non-random and therefore not reflective of the process that occurs during 
development. 
Together, these studies indicate that there are epigenetic differences between current human 
nPSCs, their in vivo counterpart, and mouse ESCs. 
Conclusion 
By the majority of measures, the most up to date culture systems produced human pluripotent cells 
with similarities to both mouse naïve ESCs and to the human preimplantation epiblast. Nonetheless, 
there are still significant discrepancies. The signalling pathways active in these cells and the 
transcription factor network they support, appear to be very similar to, yet far less stable than, their 
equivalents in mouse ESCs. It is currently not possible to say whether the reduced stability of the 
human naïve state is due to interspecies differences, suboptimal culture conditions, or the possibility 
that we have not yet isolated bona fide human nPSCs.  
Evidence from Takashima and from Guo show that their naïve cells have undergone metabolic 
reprogramming, showing a significant level of mitochondrial respiration (Figure 1, part 7) [4,5]. This 
is typically associated with mature blastocysts, with cells before and after this stage relying more 
heavily on anaerobic respiration and displaying less mature mitochondria [64,65]. Additionally, naïve 
cells show increased glycolytic metabolism, inhibition of which appears to reduce their proliferation, 
demonstrating that the high level of metabolic activity is important to the maintenance of these cells 
[66]. On the other hand, some transcriptional data suggest that the culture systems may favour a 
less mature embryonic state. Finally, several issues such as reduced viability in single cell passaging 
and genomic instability could indicate suboptimal conditions for cell growth. 
Interestingly, recent papers have identified novel hPSCs with broader chimerism and differentiation 
potential than naïve or primed cells. These respectively demonstrate the ability to form interspecies 
chimeras and the ability to differentiate into both embryonic and extraembryonic lineages in vivo 
[67,68]. The latter cells express naïve marker genes but show also an expression signature that is not 
similar to any embryonic cell type. Further characterisation of the novel human PSCs is now needed 
to ascertain their full properties and molecular signatures.  
The next major hurdles in establishing hnPSCs as the standard for in vitro studies will require 
demonstrating superior differentiation potential and reliability compared to conventional human ES 
cultures, and methods to simplify the generation and culture of these cells. By identifying cell 
surface markers specific to hnPSCs, Collier et al. [69] present a step forward in facilitating the 
establishment of naïve cultures, as well as potentially allowing the study of reprogramming 
intermediates to dissect this interesting transition. 
While the conditions for differentiation protocols may need to be optimized for these new cells, it 
will be important to learn whether the promises of more homogeneous, less cell-line dependent 
differentiation from a naïve starting population can be delivered. If so, then this cell state could take 
over to become the accepted standard starting point for drug discovery models, in vitro 
developmental studies, and possibly advances in cell therapies. 
 
 
Figure Legend 
 
Expected molecular signatures of human naïve pluripotent stem cells  
A large number of processes control, and are influenced by, any cell state. Some of the factors that 
are particularly considered in this review are: 1) The transcriptional state of the cell. Functional 
components such as Oct4 and Nanog and marker genes such as Rex1, have been identified from 
mouse naïve cells and the human preimplantation epiblast, building a fingerprint of gene expression 
that should be present in naïve cells. 2) A core transcription factor network. The naïve state in 
mouse has a self-sustaining network of transcription factors with many positive feedback loops to 
promote the maintenance of pluripotency. Notably, while many of these transcription factors are 
still expressed in primed cells, the network conformation is different, with factors binding to 
different enhancer elements and thus interacting in different ways. By exploring these 
interconnections, it is possible to test whether putative human naïve cells share the same 
connectivity and hence whether the network exists in a naïve configuration. 3 & 4) Environmental 
signals are key to maintaining cell states. In mouse, the naïve state can be maintained in vitro with 
LIF which activates downstream JAK/STAT signalling, an inhibitor of MEK/ERK signalling downstream 
of the FGF receptor, and an inhibitor of β-catenin degradation. The current human naïve culture 
conditions extend this with addition of a PKC inhibitor [4], or BRAF, SRC and ROCK inhibitors [3]. In 
addition to the response to ligands, cells interact physically with their neighbours and the 
extracellular matrix. Strong adherens junctions between cells provide the familiar dome-shaped 
morphology of naïve ESC colonies, and the ability to sense neighbours appears to be important for 
cell survival. 5) The epigenetic fingerprint of cells can be analysed in a similar manner to the 
transcriptional identity to build up a global picture of the cell state. Enhancer and promoter usage 
result in modification of histones and differential methylation of DNA. These profiles can be 
compared between cells. Additionally, the naïve state has additional epigenetic properties, such as 
global DNA hypomethylation and retention of imprinting marks which should be found in human 
naïve cells. 6) A key feature of the naïve state in female mouse cells is the presence of two active X-
chromosomes. While the exact connection between naïve identity and X-chromosome status is still 
elusive, this is considered a hallmark of the naïve identity. While aspects of X-chromosome 
regulation differ between mouse and human, recent embryo work suggests that the human 
preimplantation epiblast shares this feature with mouse. 7) Many other elements of the cell are 
controlled by the cell state. One example is the switch between aerobic and anaerobic respiration. 
The naïve compartment of the embryo is considered to be facultatively aerobic, displaying relatively 
mature mitochondria, whereas other early embryonic cell states rely on anaerobic glycolysis for 
most of their energy requirements. While the cause of this switch is unknown, it is likely to be the 
result of integrating many other state-specific signals. 
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